MDS, Inc. has entered into an agreement to sell its Analytical Technologies business to Danaher Corp. for $650 million in cash. The transaction is subject to shareholder and regulatory approval, and other closing conditions. The company also plans to sell its Pharma Services business, which provides drug discovery and early-stage development services for pharmaceutical and biotechnology companies. Following the sale of these businesses, the company’s strategic goal is to focus on its MDS Nor...